Two Small Companies See Huge Opportunities In Heart Failure Device Space
CardioKinetix And CircuLite Reach Important Milestones With Their US Clinical Trial Programs
CardioKinetix, maker of a unique, percutaneously placed ventricular partitioning device, and CircuLite, which is developing a less invasive cardiac assist device, are moving into US clinical trials with their technologies – an important milestone for emerging companies in the difficult heart failure space. Both offer therapies aimed at helping fill the huge heart failure treatment gap that exists today.